Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
Dec 11 (Reuters) - Britain's AstraZeneca on Friday said that it will begin work with Russia's Gamaleya Institute to understand whether their two COVID-19 vaccine candidates can be successfully combined.The Gamaleya Institute is the developer of Ru...
Read more(Adds detail, background.)By Silke KoltrowitzZURICH, Dec 11 (Reuters) - The emergency approval process being used by some countries to speed up the roll-out of COVID-19 vaccines is not a legal option in Switzerland, its medicines agency said on Fr...
Read more* Phase I/II results show low immune response in older adults* Setback to global efforts to develop multiple vaccines* New study expected next year using improved formulation* Sanofi hope for regulatory submission in second half of 2021 (Adds EU n...
Read more* Phase I/II results show low immune response in older adults* Setback to global efforts to develop multiple vaccines* New study expected next year using improved formulation* Hopes for regulatory submission in second half of 2021By Matthias Blamont...
Read more* Phase I/II results show low immune response in older adults* New study expected next year using improved antigen formulation* Eyes regulatory submission in the second half of 2021By Matthias BlamontPARIS, Dec 11 (Reuters) - Sanofi and GlaxoSmith...
Read moreLONDON, Dec 10 (Reuters) - Tens of thousands of people in Britain have received the Pfizer-BioNTech COVID-19 vaccine after a mass vaccination programme began earlier this week, health minister Matt Hancock said on Thursday."As of today, we are vac...
Read moreWASHINGTON, Dec 10 (Reuters) - Cyber attacks have been waged against COVID-19 vaccine distribution infrastructure, including a cold-chain storage company, U.S. Senator Gary Peters said during a congressional hearing on Thursday."IBM recently relea...
Read more(refiles with correct spelling of BioNTech in headline)BRUSSELS, Dec 10 (Reuters) - The data submitted to the European Medicines Agency (EMA) by Pfizer/BioNTech and Moderna for their COVID-19 vaccine candidates is "very robust", its executive dire...
Read more(adds details on UK allergy cases, AstraZeneca, Johnson & Johnson)BRUSSELS, Dec 10 (Reuters) - The data submitted to the European Medicines Agency (EMA) by Pfizer/BioNTech and Moderna for their COVID-19 vaccine candidates is "very robust", its ex...
Read moreLONDON, Dec 10 (Reuters) - England's COVID test and trace system is making a 500 pound ($665) support payment for people told to isolate available through its app, it said on Thursday as it outlined a plan for the next phase of the service.The su...
Read moreBy Omar MohammedNAIROBI, Dec 10 (Reuters) - Countries that have ordered more COVID-19 vaccines than they need should consider distributing excess doses to Africa, the head of the continent's disease control body said on Thursday.As African countri...
Read more
UK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne
Read moreDec 9 (Reuters) - Jenner Institute Director Adrian Hill, who oversees the Oxford-AstraZeneca COVID-19 vaccine research and development, told NBC News that if the U.S. Food and Drug Administration waits for the end of their vaccine trial, the vacc...
Read moreUK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO
Read moreBy Alexander WinningJOHANNESBURG, Dec 9 (Reuters) - Efficacy results may not be ready for months from a trial of AstraZeneca and Oxford University's coronavirus vaccine in South Africa, the principal investigator of the South African study told Re...
Read more
Last checked at